Immunoreaction cartridge for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of total Tau in human cerebrospinal fluid (CSF).
Receive your quote directly from the manufacturer.
This CSF biomarker is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's Disease and other causes of cognitive decline.
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human cerebrospinal fluid (CSF).
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of β-amyloid in human cerebrospinal fluid.
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human cerebrospinal fluid (CSF).
Lumipulse G pTau 217 Plasma is a test for in vitro diagnostic use with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA).
Lumipulse G NfL Blood is a quantitative test for in vitro diagnostic use with the automated LUMIPULSE G System for the measurement of neurofilament light chain (NfL) in human blood (serum/plasma) in patients with neurological diseases.
Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.
Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.
Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.
Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.
PreCursor-M AnoGYN is a methylation-specific molecular assay to detect promoter hypermethylation of the human genes ASCL1 and ZNF582 in bisulfite-converted DNA prepared from human samples, for instance formalin-fixed paraffin embedded anal biopsies or anal swab specimens.
Immunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human plasma.
Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma.
